Literature DB >> 11136828

Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.

V C Jordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136828     DOI: 10.1093/jnci/93.1.2

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.

Authors:  Stéphanie Légaré; Mark Basik
Journal:  Mol Endocrinol       Date:  2016-07-20

2.  Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Teresa A Phillips; Trina Metheny; Brian K Petroff; Thomas C Havighurst; KyungMann Kim; Howard H Bailey; Brandy M Heckman-Stoddard
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-21

Review 3.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells.

Authors:  Véronique Bourdeau; Julie Deschênes; David Laperrière; Malika Aid; John H White; Sylvie Mader
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

Review 5.  Chemoprevention of premalignant and malignant lesions of oral cavity: Recent trends.

Authors:  Ashish S Bodhade; Alka M Dive
Journal:  Eur J Dent       Date:  2013-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.